DATE/TIME
September 26, 9:20 – 10:00 AM EST
TITLE
Pharma’s Next Frontier: GLP-1s and Other New Therapies
SPEAKER
Ben Locwin
Chief Scientist, Head of Clinical Services and Project Solutions
ABSTRACT
In this session we’ll explore why GLP-1s and other new therapies represent the new frontier of new medicine. We’ll discuss the future of the drug industry – and why it matters, including:
• Why patient voices matter more than ever
• Why outsourcing continues to represent a key strategy for the industry
• AI in drug development: What’s on the horizon?
• Recent industry trends and what they mean looking forward
BIO
Ben Locwin is a healthcare executive and industry expert. His work has involved bringing new and innovative medical treatments (drug therapies, vaccines and medical devices) to patient populations with unmet needs across a variety of indications and health conditions. He has also worked with investors on the ‘next big things’ in the industry. He has been featured in The Wall Street Journal, Forbes, USA Today, The Associated Press and other top-tier media.
